Net Loss Per Share

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

NET LOSS PER SHARE

NOTE 17. NET LOSS PER SHARE

The following is a reconciliation of the numerator and denominator of basic and diluted net loss per share for the three and nine months ended September 30, 2016 and 2015 (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Numerator:
(Loss) income from continuing operations	$	(191,496	)	$	(803,706	)	$	109,553		$	(744,108	)
Less: Net income (loss) from continuing operations attributable to noncontrolling interests	—			(46		)	16			(153		)
(Loss) income from continuing operations attributable to Endo International plc ordinary shareholders	$	(191,496	)	$	(803,660	)	$	109,537		$	(743,955	)
Loss from discontinued operations attributable to Endo International plc ordinary shareholders, net of tax	(27,423		)	(246,782		)	(118,747		)	(632,624		)
Net loss attributable to Endo International plc ordinary shareholders	$	(218,919	)	$	(1,050,442	)	$	(9,210	)	$	(1,376,579	)
Denominator:
For basic per share data—weighted average shares	222,767			209,274			222,579			188,085
Dilutive effect of ordinary share equivalents	—			—			480			—
Dilutive effect of various convertible notes and warrants	—			—			1			—
For diluted per share data—weighted average shares	222,767			209,274			223,060			188,085

Basic net loss per share data is computed based on the weighted average number of ordinary shares outstanding during the period. Diluted loss per share data is computed based on the weighted average number of ordinary shares outstanding and, if there is net income from continuing operations attributable to Endo ordinary shareholders during the period, the dilutive impact of ordinary share equivalents outstanding during the period. Ordinary share equivalents are measured under the treasury stock method.

For the three months ended September 30, 2016, all stock options and stock awards were excluded from the diluted share calculation because their effect would have been anti-dilutive, as the Company was in a loss position. For the nine months ended September 30, 2016, stock options and stock awards of 5.0 million were excluded from the diluted share calculation because their effect would have been anti-dilutive. All stock options and stock awards were excluded from the diluted share calculation for the three and nine months ended September 30, 2015 because their effect would have been anti-dilutive, as the Company was in a loss position.